The Deal

Activists seeking to take control of boards don't need to have a CEO candidate in mind but they should produce a clear position about what they would do on day one. At least that's the view of Juan Bonifacino, director of shareholder activism defense at boutique investment bank Stifel. Bonifacino spoke to The Deal's Activist Investing Today podcast about why activists seeking to take control of boards need to provide a really compelling reason to forgo the "checks and balance" position that would come with a minority slate. The boutique investment banker spoke about Third Point's director battle at Campbell Soup as well as why he thinks companies and activists will need to spend more time talking to index funds in the years to come. He also offered up some pros and cons associated with hostile bids coupled with proxy contests. "Change of control [contests] really ratchet up the risk for a lot of unintended consequences for a company," Bonifacino said.

Timothy Doyle, the general counsel of the corporate-backed American Council for Capital Formation, spoke to the Activist Investing Today podcast about two new studies the group has produced targeting influential proxy advisory firms and “robo-voting” by some institutional investors. Doyle contends that the number of issues ACCF has identified are “just the tip of the iceberg.” He insists that companies either can’t challenge proxy advisory firms before their reports are issued, or don’t have enough time to respond.

Keith Gottfried, chief of Morgan Lewis & Bockius LLP’s shareholder activism defense practice, took some time to talk to The Deal’s Activist Investing Today podcast about how defending the company against an ex-CEO and founder of the business is so different, and perhaps much more difficult, than protecting it from an activist hedge fund. Gottfried’s comments emerge as founder and co-founder activism has skyrocketed in recent months, with high profile campaigns launched at Papa John’s, Wynn Resorts and AmTrust as well as many other companies. According to FactSet, there were 36 campaigns launched by founders, co-founders and former CEOs at companies between 2013 and 2018, so far, including 11 this year so far.

The Activist Investing Today podcast talked to Jim Chadwick, about Ancora’s activist strategy and his recent insurgencies at Hill International and Element Fleet Management. In a wide-ranging interview, Chadwick explains how working with Relational Investors Ralph Whitworth and David Batchelder, prior to joining Ancora, was "the most important factor" in his career of activism. Chadwick provides a bit of the backstory behind how Whitworth and Batchelder became pioneers in the activism strategy. "Today it has become so common, really ubiquitous throughout global markets. Back at the time 1999, when there were the Carl Icahn's of the world, but Relational may have been structured as the first pure-play activism fund," Chadwick said. "I was always fascinated with the way Ralph had conducted himself in the boardroom."

The Activist Investing Today podcast talked to Michelle Applebaum, a former steel analyst who has been nominated by insurgent managers Barington Capital and Land & Buildings for corporate boards, about why she thinks activists' analytics are quite sound. She also explains why activist investors often represent a consensus view of institutional investors, long before management has figured it out.

Activist Dan Loeb thinks Campbell Soup Co. should be sold and wants a full revamp over the board. The Deal's Senior Editor Ron Orol gave us the up-to-the-minute scoop.

Marathon Partners' manager Mario Cibelli explains why e.l.f.’s ‘fast beauty’ strategy can get its cosmetics into market faster than “legacy” rivals. While he foresees a bright future for the company, he has real concerns about executive compensation. Cibelli, 50, who succeeded in installing two dissidents onto the board of Shutterfly in 2015, also suggested that e.l.f. needs to bring on a designated lead independent director that isn’t affiliated with buyout shop TPG.

The insurgent investor Nelson Obus explains how listening in on his dad’s basement meetings put him on the road to investing, then later, Lazard banking and finally activism. In a wide-ranging conversation, Obus, 71, explains what kind of companies he finds attractive and why this year his 25-year-old fund opposed another activist investor’s director battle. He also gave us an inside look at how he shook up the board of Omega Protein, an “entrenched” company that was diversifying in all the wrong ways until Wynnefield showed up.

James Mitarotonda, who has run activist fund Barington Capital since 2000, says he takes a private-equity approach to public market investments in companies that frequently have high barriers to entry. However, Mitarotonda acknowledges that he will launch a director-election fight if necessary. For example, Barington is seeking to install two directors onto the board of Xerium Technologies as part of an effort to drive the paper machine manufacturer to explore a "strategic transaction that would facilitate the refinancing of its debt to more favorable terms." Beyond, Xerium, Mitarotonda spoke to The Deal about his efforts at Bloomin Brands and Avon, where he has a directorship.

Sloane & Co.'s Dan Zacchei, who advises both targeted companies and investors involved in activist situations, suggests that an insurgent fund manager’s track record is a key factor corporations must consider before deciding how to respond. According to Zacchei, a company that has underperformed for an extended period of time needs to be realistic about its prospects, particularly when faced with a well-respected activist. Alternatively, he argues that first-time activists with tiny funds can’t “come out of nowhere and all of a sudden think they are Carl Icahn.” The Deal spoke with Zacchei about governance, strategy and why “just vote no” campaigns should be treated seriously.